Teva’s new plant no longer idle
Executive Summary
Teva's new Jerusalem plant passed FDA inspection last month and is now operating, the generic firm announces during an analyst call Feb. 13. The plant was scheduled to be fully operational in early 2006 (1"The Pink Sheet" Aug. 14, 2006, p. 6). CEO Israel Makov says the plant started with a capacity of four billion tablets a year, with a goal to double that by year end...
You may also be interested in...
Teva’s Generic Zoloft Launch, And New Jerusalem Plant, Remain Idle
Teva's supply chain challenges appear to have caught up with the company in the form of further delays of its launch of Zoloft generics
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.